Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation ; volume:8 ; number:1 ; day:13 ; month:12 ; year:2018 ; pages:1-8 ; date:12.2018
Scientific reports ; 8, Heft 1 (13.12.2018), 1-8, 12.2018
- Creator
-
Ooi, Chee Y.
Syed, Saad A.
Rossi, Laura
Garg, Millie
Needham, Bronwen
Avolio, Julie
Young, Kelsey
Surette, Michael G.
Gonska, Tanja
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-36364-6
- URN
-
urn:nbn:de:101:1-2019012703503071948455
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ooi, Chee Y.
- Syed, Saad A.
- Rossi, Laura
- Garg, Millie
- Needham, Bronwen
- Avolio, Julie
- Young, Kelsey
- Surette, Michael G.
- Gonska, Tanja
- SpringerLink (Online service)
Other Objects (12)
Cftr deletion in mouse epithelial and immune cells differentially influence the intestinal microbiota
Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults
Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor
Intestinal Microbiota in Sepsis
Correction to: Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor
Potential of cereal grains and grain legumes for modulation of pigs’ intestinal microbiota
Modulation of the porcine intestinal microbiota in the course of Ascaris suum infection
The microbiota and intestinal diseases
Intestinal microbiota and chronic constipation
Hypergravity disrupts murine intestinal microbiota
Charakterisierung von inflammatorischen und infektiologischen Biomarkern von Kindern mit zystischer Fibrose unter neu begonnener CFTR-Modulator (Lumacaftor/ Ivacaftor) Therapie
Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants
Cftr deletion in mouse epithelial and immune cells differentially influence the intestinal microbiota
Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults
Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor
Intestinal Microbiota in Sepsis
Correction to: Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor
Potential of cereal grains and grain legumes for modulation of pigs’ intestinal microbiota
Modulation of the porcine intestinal microbiota in the course of Ascaris suum infection
The microbiota and intestinal diseases
Intestinal microbiota and chronic constipation
Hypergravity disrupts murine intestinal microbiota
Charakterisierung von inflammatorischen und infektiologischen Biomarkern von Kindern mit zystischer Fibrose unter neu begonnener CFTR-Modulator (Lumacaftor/ Ivacaftor) Therapie
Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants
Cftr deletion in mouse epithelial and immune cells differentially influence the intestinal microbiota
Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults
Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor
Intestinal Microbiota in Sepsis
Correction to: Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor
Potential of cereal grains and grain legumes for modulation of pigs’ intestinal microbiota
Modulation of the porcine intestinal microbiota in the course of Ascaris suum infection
The microbiota and intestinal diseases
Intestinal microbiota and chronic constipation
Hypergravity disrupts murine intestinal microbiota
Charakterisierung von inflammatorischen und infektiologischen Biomarkern von Kindern mit zystischer Fibrose unter neu begonnener CFTR-Modulator (Lumacaftor/ Ivacaftor) Therapie